Improving cancer research and training for diverse communities
Official title: Planning & Evaluation
Funded at University of California Riverside · NIH-10933480 · Data updated 2026-11-12
This study is all about improving cancer treatment and research by teaming up two great institutions to support and train new researchers from diverse backgrounds, making sure that everyone in Southern California has better access to clinical trials and care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $105,561 |
| NIH project number | 5U54CA285114-02 |
| Project ID | NIH-10933480 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals from diverse backgrounds who are affected by cancer and are interested in participating in clinical trials.
✕Less likely to help
Patients who are not affected by cancer or who do not reside in the targeted Southern California communities may not benefit from this research.
What this research studies
This research focuses on enhancing cancer research and drug development by building partnerships between the University of California, Riverside and the City of Hope Comprehensive Cancer Center. It aims to monitor and evaluate the progress of these partnerships in achieving their goals of capacity-building, education, and training. The initiative emphasizes diversity and equity in cancer therapeutics and aims to mentor early-stage investigators from diverse backgrounds. By involving various advisory boards, the project seeks to ensure that the needs of Southern California communities are met and that disparities in access to clinical trials are addressed.
Why it matters
Potential benefit: If successful, this research could lead to more equitable access to cancer treatments and improved outcomes for diverse patient populations.
How similar studies have gone: Similar initiatives have shown promise in enhancing diversity and equity in clinical research, indicating a potential for success in this approach.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Davis, Kendrick — University of California Riverside
- Study coordinator: Davis, Kendrick
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.